These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27101208)

  • 21. Renal drug dosing recommendations: evaluation of product information for brands of the same drug.
    Khanal A; Peterson GM; Castelino RL; Jose MD
    Intern Med J; 2014 Jun; 44(6):591-6. PubMed ID: 24946814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involuntary Weight Loss Secondary to Metformin Use in Elderly Adults.
    Pérez-Hernández O; González-Pérez JM; Martínez-Riera A; Durán-Castellón Mdel C; Monereo-Muñoz MB; Martín-González C; Santolaria-Fernández F
    J Am Geriatr Soc; 2016 Apr; 64(4):899-900. PubMed ID: 27100596
    [No Abstract]   [Full Text] [Related]  

  • 23. Metformin: evidence-based versus rational pharmacotherapy.
    Smits P; Tack CJ
    Neth J Med; 2002 Jul; 60(6):228-30. PubMed ID: 12365465
    [No Abstract]   [Full Text] [Related]  

  • 24. The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD Injury.
    Rutkowski MP
    J Am Soc Nephrol; 2020 Nov; 31(11):2740. PubMed ID: 32936781
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metformin role in the treatment of type 2 diabetes in 2008].
    Spada A; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin: an advance in ovulation induction.
    Turner MJ; Langan H; Farah N; Byrne K; Cleary B
    Ir Med J; 2005 May; 98(5):133-4. PubMed ID: 16010777
    [No Abstract]   [Full Text] [Related]  

  • 27. The target of metformin in type 2 diabetes.
    Ferrannini E
    N Engl J Med; 2014 Oct; 371(16):1547-8. PubMed ID: 25317875
    [No Abstract]   [Full Text] [Related]  

  • 28. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin in patients with chronic kidney disease: strengths and weaknesses.
    Rocha A; Almeida M; Santos J; Carvalho A
    J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin for patients with diabetes and concomitant renal restrictions--is there an evidence base?
    Sharif A
    QJM; 2013 Mar; 106(3):291-4. PubMed ID: 23349404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medication of the month. Sitagliptin-metformin fixed combination (Janumet)].
    Scheen AJ
    Rev Med Liege; 2010 Nov; 65(11):648-54. PubMed ID: 21189532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin and insulin meet in a most atypical way.
    White MF
    Cell Metab; 2009 Jun; 9(6):485-7. PubMed ID: 19490902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristic of metformin for treatment of impaired glucose tolerance].
    Ishida W; Satoh J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
    [No Abstract]   [Full Text] [Related]  

  • 35. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).
    Viswanathan V; Chacko PT; Lavanya M; Tilak P
    J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022
    [No Abstract]   [Full Text] [Related]  

  • 36. Metformin and pancreatic cancer: a clue requiring investigation.
    Pollak M
    Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure.
    Adam WR; O'Brien RC
    Diabet Med; 2014 Sep; 31(9):1032-8. PubMed ID: 24909998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
    Rosilio C; Ben-Sahra I; Bost F; Peyron JF
    Cancer Lett; 2014 May; 346(2):188-96. PubMed ID: 24462823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishing pragmatic estimated glomerular filtration rate thresholds to guide metformin prescribing: careful assessment of risks and benefits is required.
    George JT; McKay GA
    Diabet Med; 2008 May; 25(5):636-7. PubMed ID: 18346163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.